secwatch.observer — SEC 8-K summary
======================================

Issuer:     Matinas BioPharma Holdings, Inc. (MTNB)
CIK:        0001582554
Form:       8-K
Filed at:   2021-09-20T23:59:59+00:00
Accession:  0001493152-21-023087
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Matinas BioPharma nominates Kathryn Penkus Corzo to board; LePore not standing for re-election
--------------------------------------------------------------------------------

- Patrick LePore will not stand for re-election at the 2021 Annual Meeting on November 1, 2021.
- Kathryn Penkus Corzo nominated to stand for election to the Board at the same meeting.
- Corzo is a partner at Takeda Ventures and formerly Head of Oncology Cell Therapy Development at Takeda.
- LePore served as Vice Chairman and was thanked for his three years of service.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1582554/000149315221023087/0001493152-21-023087-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1582554/000149315221023087/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-21-023087

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer